Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald K Pearson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Safety|November 17, 2010
An experimental investigation of masking in the US FDA adverse event reporting system databaseHsin-wei Wang, Alan M Hochberg, Ronald K Pearson, et al.
Drug Safety|February 25, 2009
Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting SystemAlan M Hochberg, Ronald K Pearson, Donald J O'Hara, et al.
Journal of Clinical Pharmacology|May 20, 2009
Systematic investigation of time windows for adverse event data mining for recently approved drugsAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
Omics : a Journal of Integrative Biology|December 20, 2003
Continuous-time identification of gene expression modelsDaniel E Zak, Ronald K Pearson, Rajanikanth Vadigepalli, et al.
Investigative Ophthalmology & Visual Science|April 29, 2008
Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetesAbdhish R Bhavsar, Lisa R Grillone, Timothy R McNamara, et al.
International Journal of Medical Informatics|February 24, 2009
Influence of the MedDRA hierarchy on pharmacovigilance data mining resultsRonald K Pearson, Manfred Hauben, David I Goldsmith, et al.
Drug Safety|May 23, 2009
An evaluation of three signal-detection algorithms using a highly inclusive reference event databaseAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Safety|November 17, 2010
An experimental investigation of masking in the US FDA adverse event reporting system databaseHsin-wei Wang, Alan M Hochberg, Ronald K Pearson, et al.
Drug Safety|February 25, 2009
Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting SystemAlan M Hochberg, Ronald K Pearson, Donald J O'Hara, et al.
Journal of Clinical Pharmacology|May 20, 2009
Systematic investigation of time windows for adverse event data mining for recently approved drugsAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
Omics : a Journal of Integrative Biology|December 20, 2003
Continuous-time identification of gene expression modelsDaniel E Zak, Ronald K Pearson, Rajanikanth Vadigepalli, et al.
Investigative Ophthalmology & Visual Science|April 29, 2008
Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetesAbdhish R Bhavsar, Lisa R Grillone, Timothy R McNamara, et al.
International Journal of Medical Informatics|February 24, 2009
Influence of the MedDRA hierarchy on pharmacovigilance data mining resultsRonald K Pearson, Manfred Hauben, David I Goldsmith, et al.
Drug Safety|May 23, 2009
An evaluation of three signal-detection algorithms using a highly inclusive reference event databaseAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
Pageof 1